Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
出版年份 2013 全文链接
标题
Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
作者
关键词
Collagens, Fibrosis, Diet, Inflammation, Nitric oxide, Steatosis, Fatty liver, Protein expression
出版物
PLoS One
Volume 8, Issue 10, Pages e76538
出版商
Public Library of Science (PLoS)
发表日期
2013-10-03
DOI
10.1371/journal.pone.0076538
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver
- (2014) Małgorzata Trocha et al. Pharmacological Reports
- Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling
- (2012) Sang-Heng Kok et al. ARTHRITIS AND RHEUMATISM
- MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression
- (2012) Tsuyoshi Tabuchi et al. CLINICAL SCIENCE
- If steatosis is the atherosclerosis of the liver, are statins the “aspirin” for steatosis?
- (2012) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
- (2012) Hideyuki Hyogo et al. DIGESTIVE AND LIVER DISEASE
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease
- (2012) Rui E. Castro et al. JOURNAL OF HEPATOLOGY
- Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?
- (2012) Giovanni Tarantino et al. Journal of Translational Medicine
- Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats
- (2012) Yoshihisa Okada et al. LIVER INTERNATIONAL
- Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats
- (2011) Tomokatsu Miyaki et al. HEPATOLOGY RESEARCH
- Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
- (2010) Z. M. YOUNOSSI ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
- (2010) Giovanni Tarantino WORLD JOURNAL OF GASTROENTEROLOGY
- Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
- (2009) Zheng-Jie Xu et al. DIGESTIVE DISEASES AND SCIENCES
- Impact of Simvastatin on Adipose Tissue: Pleiotropic Effectsin Vivo
- (2009) Tayeba Khan et al. ENDOCRINOLOGY
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease
- (2009) Masato Yoneda et al. HEPATOLOGY RESEARCH
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
- (2009) Takeharu Asano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pathogenesis of non-alcoholic fatty liver disease
- (2009) J. K. Dowman et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management
- (2008) Raj Vuppalanchi et al. HEPATOLOGY
- Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-β1 in a cultured stellate cell line
- (2008) Shigeru Nakano et al. HEPATOLOGY RESEARCH
- Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis
- (2008) Tung-Ming Leung et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Non-alcoholic fatty liver disease: The mist gradually clears
- (2008) Nimantha Mark Wilfred de Alwis et al. JOURNAL OF HEPATOLOGY
- Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?
- (2008) Giovanni Tarantino et al. Journal of Translational Medicine
- Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
- (2008) G MUSSO et al. PROGRESS IN LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started